z-logo
open-access-imgOpen Access
Zinc transporter 8 ( Z n T 8) autoantibody epitope specificity and affinity examined with recombinant Z n T 8 variant proteins in specific Z n T 8 R and Z n T 8 W autoantibody‐positive type 1 diabetes patients
Author(s) -
Skärstrand H.,
Krupinska E.,
Haataja T. J. K.,
VaziriSani F.,
Lagerstedt J. O.,
Lernmark Å.
Publication year - 2015
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.12448
Subject(s) - autoantibody , recombinant dna , epitope , autoimmunity , immunology , amino acid , type 1 diabetes , antibody , biology , diabetes mellitus , medicine , endocrinology , biochemistry , gene
Summary Variant‐specific zinc transporter 8 autoantibodies ( Z n T 8 A ) against either arginine ( R ) or tryptophan ( W ) at amino acid (aa) position 325 of the zinc transporter 8 ( Z n T 8) has been identified in type 1 diabetes ( T 1 D) patients. Reciprocal cross‐over tests revealed differences in half‐maximal binding to indicate variable affinity of patient Z n T 8 autoantibodies. Insufficient recombinant Z n T 8 variant proteins have precluded detailed analyses of Z n T 8 autoantibody affinity. The aims in the present study were to (i) generate recombinant Z n T 8 R ‐ and Z n T 8 W ‐aa275‐369 proteins; (ii) test the Z n T 8 R ‐ and Z n T 8 W ‐aa275‐369 proteins in reciprocal competitive radiobinding assays ( RBA ) against Z n T 8 R ‐ and Z n T 8 W ‐aa268‐369 labelled with 35 S ‐methionine; and (iii) determine the specificity and affinity of sera specific for either Z n T 8 arginine ( R ) or Z n T 8 tryptophan ( W ) autoantibodies in newly diagnosed T 1 D patients. The results demonstrate, first, that it was possible to produce recombinant human MBP – Z n T 8‐aa275‐369 protein purified to homogeneity for RBA reciprocal competition experiments. Secondly, high‐titre Z n T 8 WA sera diluted to half maximal binding showed significant specificity for respective variants of either Z n T 8 R or Z n T 8 W . Thirdly, Z n T 8 WA ‐positive sera showed high affinity for Z n T 8 W compared to Z n T 8 RA for Z n T 8 R . These data demonstrate that T 1 D patients may have single amino acid‐specific autoantibodies directed against either Z n T 8 R or Z n T 8 W and that the autoantibody affinity to the respective variant may be different. Further studies are needed to assess the mechanisms by which variant‐specific Z n T 8 A of variable affinity develop and their possible role in the pathogenic process leading to the clinical onset of T 1 D .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom